Care Pharmacies

"FDA Approves Afrezza for Diabetes Control at Mealtime"

New inhaled insulin treatment gets FDA approval for mealtime blood sugar control

(dailyRx News) The US Food and Drug Administration has approved a new medication to improve blood sugar control in adults with diabetes.

The new medication is called Afrezza (insulin human) Inhalation Powder. Afrezza is a rapid-acting inhaled insulin used at the start of each meal or within 20 minutes of beginning a meal.

Insulin is a naturally occurring hormone that helps to manage blood sugar levels. In people with diabetes, the body either does not produce insulin (type 1 diabetes) or does not respond properly to insulin (type 2 diabetes). Blood sugar can rise to potentially harmful levels in these patients, especially after eating a meal.

Afrezza, and other fast-acting insulins, are used to correct high blood sugar during meals and snacks.

Read more from RxWiki HERE.